Home > National Drug Code (NDC) > Lithium Carbonate

Lithium Carbonate - 0054-2527-31 - (Lithium Carbonate)

Alphabetical Index


Drug Information of Lithium Carbonate

Product NDC: 0054-2527
Proprietary Name: Lithium Carbonate
Non Proprietary Name: Lithium Carbonate
Active Ingredient(s): 300    mg/1 & nbsp;   Lithium Carbonate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, GELATIN COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Lithium Carbonate

Product NDC: 0054-2527
Labeler Name: Roxane Laboratories, Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA017812
Marketing Category: NDA
Start Marketing Date: 19801126

Package Information of Lithium Carbonate

Package NDC: 0054-2527-31
Package Description: 1000 CAPSULE, GELATIN COATED in 1 BOTTLE (0054-2527-31)

NDC Information of Lithium Carbonate

NDC Code 0054-2527-31
Proprietary Name Lithium Carbonate
Package Description 1000 CAPSULE, GELATIN COATED in 1 BOTTLE (0054-2527-31)
Product NDC 0054-2527
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lithium Carbonate
Dosage Form Name CAPSULE, GELATIN COATED
Route Name ORAL
Start Marketing Date 19801126
Marketing Category Name NDA
Labeler Name Roxane Laboratories, Inc
Substance Name LITHIUM CARBONATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Mood Stabilizer [EPC]

Complete Information of Lithium Carbonate


General Information